SCHEMBL30260573

SCHEMBL30260573

N[C@@H](Cc1ccc2oc3cc(=O)c4ccccc4c-3nc2c1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRA P18433 1/20 1.00
PTPRB P23467 1/20 1.00
HIF1A Q16665 2/20 0.89
ALDH1A1 P00352 1/20 0.89
CYP1A2 P05177 1/20 0.89
CYP3A4 P08684 1/20 0.89
BRCA1 P38398 1/20 0.89
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
RAB9A P51151 1/20 0.46
PKM P14618 2/20 0.46
SLC7A5 Q01650 4/20 0.41
PTGS1 P23219 3/20 0.41
ALPI P09923 1/20 0.41
XIAP P98170 1/20 0.41
KDM4E B2RXH2 2/20 0.40
USP2 O75604 2/20 0.40
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23483908 1.00 PTPRA (1.00) PTPRAPTPRBHIF1AALDH1A1CYP1A2
SCHEMBL29470816 1.00 PTPRA (1.00) PTPRAPTPRBHIF1AALDH1A1CYP1A2
SCHEMBL27337933 1.00 PTPRA (1.00) PTPRAPTPRBHIF1AALDH1A1CYP1A2
Nitric Acid SCHEMBL30472695 0.94 HIF1A (1.00) PTPRAPTPRBHIF1AALDH1A1CYP1A2
SCHEMBL15087108 0.92 PTPRA (0.84) PTPRAPTPRBHIF1AALDH1A1CYP1A2
SCHEMBL25016361 0.81 PTPRA (0.69) PTPRAPTPRBHIF1AALDH1A1CYP1A2
SCHEMBL14679079 0.80 PTPRA (0.66) PTPRAPTPRBHIF1AALDH1A1CYP1A2
SCHEMBL1068031 0.76 PTPRA (0.61) PTPRAPTPRBHIF1AALDH1A1CYP1A2
SCHEMBL1068034 0.76 PTPRA (0.61) PTPRAPTPRBHIF1AALDH1A1CYP1A2
Leucine SCHEMBL3275050 0.75 PTPRA (0.60) PTPRAPTPRBHIF1AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230044407-A1 TARGETING MB2 OF THE MYC ONCOGENE AND ITS INTERACTION WITH TRRAP IN CANCER THE TRUSTEES OF DARTMOUTH COLLEGE 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230044407-A1 TARGETING MB2 OF THE MYC ONCOGENE AND ITS INTERACTION WITH TRRAP IN CANCER MYCBP, MYC, TERF2IP PTPRA 1048/4885PTPRB 951/4885HIF1A 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.